- $3.80m
- $14.48m
2019 June 30th | C2020 June 30th | 2021 June 30th | R2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2.02 | 1.64 | 2.37 | 1.88 | 0 |
Cost of Revenue | |||||
Gross Profit | — | 0.935 | 0.909 | — | — |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 17.8 | 15.6 | 33.5 | 31.6 | 29.3 |
Operating Profit | -15.8 | -14 | -31.1 | -29.7 | -29.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -17.6 | -16.4 | -23.2 | -29.5 | -29.3 |
Net Income After Taxes | -17.6 | -16.4 | -23.2 | -29.5 | -29.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -17.6 | -16.4 | -23.2 | -50.3 | -65 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -17.9 | -38.3 | -23.5 | -50.4 | -65 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -472 | -305 | -60 | -63.8 | -47 |